Ankle Osteoarthritis
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
DT MedTechNetherlands - s-Hertogenbosch
1 programHintermann Series H3 Total Ankle Replacement SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
DT MedTechHintermann Series H3 Total Ankle Replacement System
UNION therapeuticsAnkle Foot Orthosis
Clinical Trials (2)
Total enrollment: 301 patients across 2 trials
Post- Approval Hintermann Series H® Study 1
Start: Jun 2020Est. completion: Jan 2025298 patients
N/AActive Not Recruiting
Efficacity of a Rigid Ankle Foot Orthosis for Persons With Ankle Osteoarthritis
Start: Feb 2017Est. completion: Dec 20173 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.